A 99% purity figure on a peptide certificate is the main peak’s share of UV peak area in one chromatogram, recorded at one wavelength on one column under one gradient. It is not the share of the vial’s weight that is peptide.
The number describes what the detector saw and separated. Water, counterions, salts and anything hidden under the main peak sit outside it, so reading it well means knowing the method behind it.
Peptide HPLC purity is the most quoted line on a certificate and the one most often misread. This article covers how the figure is calculated, what falls outside it, which impurities it is designed to catch and which companion tests close the gaps. For the other fields on the page, see reading a certificate of analysis line by line.
How peptide HPLC purity is calculated
In reversed-phase HPLC, the sample runs through a C18 column while the mobile phase shifts from mostly water toward more acetonitrile. Molecules leave the column at different times depending on how strongly they bind, and a UV detector records absorbance as they pass. Peptide bonds absorb strongly in the far ultraviolet, so peptide detection generally runs at 210 to 220 nm. Many methods read at 214 nm, inside that band.
Software draws a baseline under each peak and integrates its area. The purity figure is the main peak’s area divided by the total area of all integrated peaks, times 100. The numbers below are illustrative only and describe no real batch.
| Peak | Area (illustrative units) | Area percent |
|---|---|---|
| Impurity A | 40 | 0.40 |
| Main peak | 9,900 | 99.00 |
| Impurity B | 35 | 0.35 |
| Impurity C | 25 | 0.25 |
| All integrated peaks | 10,000 | 100.00 |
The calculation assumes every species gives a comparable signal, which is only approximately true. At 214 nm, tryptophan absorbs about 30 times more than a peptide bond, and phenylalanine, tyrosine and histidine about six times more. An impurity missing a tryptophan absorbs less per molecule than the full peptide, so its peak understates its amount.
What the purity number cannot see
A chromatogram counts only what absorbs at the chosen wavelength, elutes inside the run and separates from its neighbors. Three kinds of material fail one or more of those tests.
- Co-eluting peptides. An impurity that leaves the column with the main peptide adds to the main peak’s area. In one LC-HRMS study of a synthetic peptide, UV purity at 214 nm was 94.7% while the mass spectrometry figure was 74.8%, because several peptides sat under the main UV peak.
- Water. Residual moisture in a lyophilized powder has no UV peak and needs a separate test, such as Karl Fischer titration.
- Counterions and salts. Synthetic peptides are isolated as salts. The counterion and any inorganic ions add weight but sit outside the purity calculation.
A mass balance study of synthetic glucagon measured trifluoroacetic acid at about 103 mg per gram and water at about 50 mg per gram, and placed the glucagon content at about 896 mg per gram once every impurity was subtracted. In a 2025 study of trifluoroacetate counterions, the counterion reached up to 35% of total weight in some peptide salts, and exchanging it for chloride had no impact on measured purity.
Chromatographic purity
The main peak’s share of integrated UV peak area. It compares UV-absorbing species with each other and says nothing about weight.
Net peptide content
The share of the powder’s weight that is the peptide itself, after water, counterions and other non-peptide material are accounted for. It needs separate tests, such as ion chromatography and Karl Fischer titration.
Purity asks how clean the peptide fraction is. Content asks how much of the powder is peptide. A certificate can answer the first well and say nothing about the second.
Impurities the method is designed to catch
Most synthetic peptides today are made by solid phase peptide synthesis, where any coupling or deprotection step can fall short. A review of related impurities in peptide medicines sorts the results into synthesis-related and degradation-related families. RP-HPLC is meant to separate these from the target.
- Deletion and insertion sequences. Chains missing a residue after inefficient Fmoc deprotection, or carrying an extra one from excess amino acid reagent. In the LC-HRMS study above, several co-eluted with the main peak.
- Incomplete deprotection. Side chain protecting groups that were never removed stay attached, such as leftover Fmoc or t-butyl groups.
- Racemization. Fmoc deprotection can convert a residue from the L to the D form, giving a diastereomer. The HPLC chapter cited earlier shows L and D peptide pairs that separated at one column temperature and co-eluted at higher and lower ones.
- Oxidation. Oxidized side chains appear in the review and among the co-eluting impurities in the LC-HRMS study.
- Deamidation. Asparagine residues deamidate without any enzyme through a cyclic succinimide intermediate, leaving aspartic acid and isoaspartic acid in about a 1 to 3 ratio. The review lists succinimide formation among peptide degradation routes.
A certificate describes a batch on its test date. Deamidation proceeds spontaneously, so conditions after release matter too; see cold chain in transit and the first hour after a box arrives.
Why identity needs mass spectrometry
A UV peak carries two facts: when it eluted and how much light it absorbed. Neither names the molecule. A wrong sequence or a different peptide altogether can produce one clean peak and a high area percent.
Mass spectrometry measures the molecular mass of what is in the peak and compares it with the mass calculated from the intended sequence. Tandem mass spectrometry fragments the peptide as well; in the LC-HRMS study, fragment ions confirmed the sequence and both terminal modifications.
The FDA guidance on validating analytical procedures puts the principle generally: a procedure that lacks specificity should be compensated by other procedures, and where one does not discriminate enough, a combination of two or more is recommended. HPLC for purity with mass spectrometry for identity is that combination.
Mass spectrometry has its own blind spot. An L residue and a D residue weigh the same, so a diastereomer passes a mass check. That part of the job falls to chromatographic separation.
Method details that belong next to the number
A purity value without its method cannot be compared with any other. Change the column, gradient, temperature or wavelength and the same powder can give a different figure, because separated peaks merge or merged peaks come apart.
- Column and mobile phase. The stationary phase, such as C18, the solvents and the gradient program. Trifluoroacetic acid is widely used as the ion-pairing reagent, one reason peptides end up as trifluoroacetate salts.
- Wavelength. A far UV setting such as 214 nm sees every peptide bond. A reading at 250 to 290 nm depends on aromatic side chains, which not every peptide carries.
- Column temperature. Temperature shifts selectivity, as the L and D example shows.
- Integration settings. Where baselines were drawn, the smallest peak counted and the length of the run. Dropping small peaks from the total raises the result.
- Resolution and the chromatogram. The validation guidance names resolution of the two closest eluting components as one way to show specificity. An attached chromatogram lets a reader see it.
What to check on a certificate
A useful certificate lets a reader rebuild the claim from what is printed.
- The testing laboratory named, with its own signed report
- A batch number that matches the vial
- The test date
- The method stated: column, gradient and wavelength
- A chromatogram with integrated peaks, not only a number
- Identity by mass spectrometry, with observed and expected mass
- Water and counterion results wherever net peptide content is claimed
Imperial Biolab batches are tested by an accredited third party laboratory in the United States, by RP-HPLC on a C18 column with UV detection at 214 nm and identity by LC-MS. The batch number on each vial, and a QR code on the label, lead to that exact batch’s certificate, with the laboratory’s own signed report. Certificates stay in the certificate library after a batch sells out. Questions about a certificate can go through the contact page.
- HPLC purity is the main peak’s share of UV peak area under one method
- It is not the share of the vial’s weight that is peptide
- Water, counterions and salts sit outside the number and need their own tests
- Impurities that co-elute with the main peak count as main peak
- Identity needs mass spectrometry, and the number needs its method stated
Frequently asked questions
No. HPLC purity is the main peak’s share of integrated UV peak area, so it compares UV-absorbing species with each other. Net peptide content is the share of the powder’s weight that is the peptide, after water, counterions and salts are subtracted. A sample can show high purity while much of its weight is counterion and moisture.
Peptide bonds absorb strongly in the far ultraviolet, so every peptide gives a signal there, with or without aromatic residues. Detection generally runs between 210 and 220 nm. The response still varies: tryptophan, phenylalanine, tyrosine and histidine absorb more than a peptide bond, so area percent only approximates relative amount.
Yes. HPLC purity says the main peak dominates the chromatogram, not what the main peak is. A wrong or altered sequence can elute as one clean peak. Identity needs mass spectrometry, which compares the measured molecular mass with the mass expected from the sequence.
TFA is trifluoroacetic acid, the cleavage agent in solid phase peptide synthesis and a common ion-pairing reagent in purification, so synthetic peptides are often isolated as trifluoroacetate salts. The counterion adds weight without moving the HPLC purity figure. In the studies above it made up about a tenth of one sample’s weight and up to about a third of others.
The figure belongs to a method. A different column, gradient, temperature or wavelength can separate impurities that another method merges into the main peak, and integration settings decide which small peaks enter the total. Results are only comparable when both certificates state their methods.
- Mant CT, Chen Y, Yan Z, et al., 2007. HPLC analysis and purification of peptides. Methods in Molecular Biology, 386, 3 to 55. DOI
- Kuipers BJ, Gruppen H, 2007. Prediction of molar extinction coefficients of proteins and peptides using UV absorption of the constituent amino acids at 214 nm to enable quantitative reverse phase high-performance liquid chromatography-mass spectrometry analysis. Journal of Agricultural and Food Chemistry, 55(14), 5445 to 5451. DOI
- Ranbaduge N, Yu YQ, 2018. Synthetic peptide characterization and impurity profiling using a compliance-ready LC-HRMS workflow. Waters Corporation application note 720006367. View source
- Wang X, Zhang F, Li H, et al., 2020. Purity determination of synthetic glucagon using a mass balance approach. Scientific Reports, 10, 4423. DOI
- Erckes V, Streuli A, Chamera Rendueles L, et al., 2025. Towards a consensus for the analysis and exchange of TFA as a counterion in synthetic peptides and its influence on membrane permeation. Pharmaceuticals, 18(8), 1163. DOI
- D’Hondt M, Bracke N, Taevernier L, et al., 2014. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis, 101, 2 to 30. DOI
- Kato K, Nakayoshi T, Kurimoto E, et al., 2020. Mechanisms of deamidation of asparagine residues and effects of main-chain conformation on activation energy. International Journal of Molecular Sciences, 21(19), 7035. DOI
- Q2(R2) Validation of Analytical Procedures: Guidance for Industry. FDA, March 2024. View source
This article is general educational information about laboratory analysis and material handling. It is not medical, legal or regulatory advice, and nothing in it describes or recommends the use of any compound in people or animals. Materials supplied by Imperial Biolab are for research use only: not for human or veterinary use, not for diagnostic use, and not for use as a food, drug, dietary supplement or cosmetic. Sale is restricted to adults aged 21 or over. See the research use disclaimer for details.

